top of page
Validated by nature
Derisked by AAV
Engineered to treat elusive diseases
Carbon Biosciences is a team of passionate drug developers extending the reach of genetic medicines for the treatment of devastating diseases. We combine the genetic diversity and potency of viruses that have evolved over millions of years with the recent clinical and manufacturing advances in the gene therapy field. Our proprietary CBN vector library has the potential advantages of exquisite tissue specificity, larger payloads and durable treatment strategies across multiple modalities. Our goal: realize the power of natural viral evolution and deliver on the promise of genetic medicines.
Our Team
TEAM
MANAGEMENT
BOARD OF DIRECTORS
SCIENTIFIC ADVISORY BOARD
News & Media
NEWS
9/26/2022
6/24/2022
BioWorld
Carbon Biosciences takes aim at cystic fibrosis, launching with $38M toward next-gen gene therapy
6/23/2022
6/21/2022
Fierce Biotech
Carbon Biosciences exits stealth with $38M, unveils cystic fibrosis gene therapy candidate
6/21/2022
Endpoints News
Carbon Biosciences emerges with a new viral vector to shake up the cystic fibrosis gene therapy field
6/21/2022
Careers
Contact
CAREERS
We are a team of passionate drug developers extending the reach of genetic medicines for the treatment of devastating diseases.
Interested in joining the Carbon Bio team? Visit our Career Center
Carbon Biosciences
880 Winter Street, Suite 2001
Waltham, MA 02451 USA
© 2024 Carbon Biosciences
bottom of page